American families across the country are feeling the devastating impacts of fentanyl, addiction, and overdose. In response, the federal government is dramatically cutting funding for proven health and treatment solutions that keep people alive and healthy. As a result, healthcare costs are climbing, waitlists for addiction treatment can be weeks or months long, and the cost of living for essential human needs like food and housing are rising. Proposed and recently approved cuts will make this situation dire.
“Programs I serve have reduced or eliminated important services for people who use drugs. This has led to job loss, economic despair, and a further strain on organizations and service providers who were already at maximum capacity. Funding cuts = lives lost, full stop.”
“We are in a rural area, so any cuts to addiction treatment and overdose prevention makes already slim and hard to access resources even more inaccessible.”
“So many people are not receiving the treatment they deserve and need…People are dying. Loved ones are suffering.”
A recent analysis shows that 400 hospitals across the U.S. are at risk of closing or drastically reducing services due to President Trump’s “Big, Beautiful Bill.” The Trump administration’s proposed FY2027 budget, stacked on top of previous cuts, would slash even more. If implemented, this would be a major blow to the public health infrastructure that keeps the country’s treatment, overdose prevention, and addiction research systems running.
El recent decline in overdose deaths shows that when people can access treatment, overdose prevention tools, and health services, communities are safer and lives are saved. Without reliable funding for drug prevention and treatment programs, community health services, and overdose prevention tools like naloxone, communities spiral into crises: symptoms of mental health and substance use increase strain on local systems, public drug use risks becoming more visible, communities become less safe, and taxpayers face higher costs while lives continue to be lost.
Federal funding has been clawed back from communities across the country, destabilizing the lifesaving work of public health and behavioral health professionals. The federal staff who oversaw our nation’s response to the overdose crisis have been laid off in chaotic firings, jeopardizing critical substance use data that guides and measures the impact of our policy decisions. And recent guidance from the federal government attempts to cut off SAMHSA funding for tools like fentanyl test strips, which help people avoid using fentanyl. Now, the Trump administration is proposing even more devastating cuts to care.
The Trump administration’s FY2027 budget proposal would escalate this crisis dramatically by cutting an additional $10 billion, shuttering treatment and mental health services nationwide. In addition to slashing community-based treatment and overdose response, and closing health centers and youth prevention programs, the administration’s proposed cuts will:
Even before Trump’s budget proposal for FY2027, families and communities felt the consequences of federal budget decisions which have already cut:
Policymakers and communities need to understand the massive scale of the cuts and their real-world consequences on community safety and health. We must come together to fight for investments that keep people alive, healthy, and supported. Join us in speaking out against these cuts and calling for investment in health solutions that work.
La Alianza de Políticas de Drogas y el Centro de Acción Legal are tracking these threats. Read our full analysis below.
The Substance Abuse and Mental Health Services Administration (SAMHSA) funds treatment programs, medications for opioid use disorder, naloxone distribution, and helps connect people—especially in rural and underserved communities—to care. Despite SAMHSA’s central role in addressing the overdose crisis nationwide, the Trump administration is choosing to dismantle it by reducing its funding and workforce.
En Milwaukee, Wisconsin, Meta House ofrece tratamiento de adicciones específicamente para mujeres, ofreciendo servicios ambulatorios y residenciales que también apoyan a sus hijos. Solo en 2024Meta House atendió a 331 mujeres y 168 niños. Las usuarias que permanecieron en atención ambulatoria durante al menos 90 días mostraron altas tasas de abstinencia o un menor consumo. Sin las subvenciones de SAMHSA, este programa en Wisconsin no sería posible y cientos de mujeres podrían quedar sin tratamiento ni atención para la adicción, y sus familias sin apoyo.
Los Institutos Nacionales de la Salud (NIH), principalmente a través del Instituto Nacional sobre el Abuso de Drogas (NIDA), lideran la investigación científica, los ensayos clínicos y la educación pública para comprender, prevenir y tratar la adicción. Financian estudios sobre cómo el consumo de sustancias afecta el cerebro y el cuerpo, y desarrollan y prueban medicamentos y terapias conductuales para el tratamiento de la adicción. Si bien la investigación sobre drogas y adicciones es ahora más necesaria que nunca, la administración Trump y el Congreso están recortando subvenciones vitales y despidiendo a nuestros principales expertos e investigadores. For a deeper analysis of the impact on NIH research cuts, read our fact sheet here.
The Trump administration has proposed collapsing the two institutes in the NIH that focus on substance use (i.e. National Institute on Alcohol Abuse & Alcoholism and National Institute on Drug Abuse) into one center, reducing their funding by $165 million from 2026 levels. This restructuring would dramatically impact the way that addiction science is conducted, create increased competition for limited funding opportunities, and risk destabilizing ongoing addiction research and training projects.
Muchos estudios y ensayos clínicos críticos sobre adicción se encuentran actualmente en suspenso, lo que tendrá un impacto mundial, ya que el NIDA (dentro de los NIH) financia 85% de la investigación global sobre adicción. Dejar esta investigación en suspenso pone en peligro el progreso futuro en medicamentos, tratamientos conductuales y prevención de sobredosis.
The Centers for Disease Control and Prevention (CDC) supports health centers, overdose prevention, and public health surveillance across the country. It funds local health departments that provide frontline overdose prevention and infectious disease prevention services. They also collect and analyze national overdose data.
The CDC’s Injury Prevention and Control activities would be moved to the Administration for a Healthy America, with its funding cut by more than $173 million from current funding levels. The Division of Overdose Prevention, housed within the Injury Prevention Center, is tasked with monitoring, preventing, and reducing the harms associated with drug use, misuse, and overdose. HHS restructuring would disrupt our federal response to overdose, undercutting our ability to identify and address emerging drug trends.
The Department of Justice (DOJ) funds addiction treatment and recovery programs for people involved in the criminal legal system. These individuals have high rates of addiction and are also at increased risk of overdose. DOJ funds are used for things like alternatives to incarceration and programs that respond to health emergencies and connect people to lifesaving services. If further DOJ cuts go through, it will create barriers to treatment and recovery with higher risk of overdose for people involved in the criminal legal system. It would also threaten programs that have successfully diverted people with first-time drug offenses from jail to treatment.
Approximately 30 grant programs that were historically funded at más de $1 mil millones would be eliminated. Some of these programs focused on forensic support for opioid and synthetic drug investigations, which improved our understanding of fatal overdoses and the drug supply, and mentoring for youth affected by the opioid crisis.
Por ejemplo, en Carolina del Norte, el Proyecto Lázaro, una organización sin fines de lucro creada en respuesta a las altísimas tasas de mortalidad por sobredosis en el condado de Wilkes, perdió su subvención del Departamento de Justicia. Esto resultará en menos segundas oportunidades, más encarcelamientos y un retroceso en el progreso de una comunidad que ya ha luchado arduamente para reducir las muertes por sobredosis.
The Trump administration has already cut nearly $1 trillion from federal funding for lifesaving overdose prevention, addiction treatment, and public health services. And now they are trying to slash $10 billion more—gutting critical programs funded by SAMHSA, the CDC, NIH, and DOJ. These devastating cuts would strip communities of lifesaving tools like naloxone, fentanyl test strips, and addiction treatment.
The result? More overdoses. Fewer treatment options. Less help during a crisis. A public health emergency made worse.
But we’ve faced impossible fights before—and won. The Drug Policy Alliance fought for naloxone, medications that reduce overdose risk, and fentanyl test strips when few others would. Today, those tools are saving lives and have bipartisan support. And despite demands for massive cuts by the Trump administration, we urged Congress to protect critical funding for overdose prevention and addiction treatment in the FY2026 federal budget.
Now we need your help to do it again in the next budget.
Si tiene preguntas o consultas sobre el rastreador, envíe un correo electrónico a [email protected].
Este proyecto es una colaboración entre la Alianza de Políticas de Drogas y el Centro de Acción Legal. Recopilamos datos para este proyecto de diversas fuentes, incluyendo noticias, información publicada por el gobierno federal y reportajes no oficiales dirigidos por miembros actuales y anteriores del gobierno. Obtenga más información sobre nuestras fuentes de datos y metodología aquí.
El Alianza de Políticas de Drogas (DPA) Aborda los daños del consumo de drogas y su criminalización a través de soluciones políticas, organización y educación pública. Abogamos por un enfoque holístico de las drogas que priorice la salud, el apoyo social y el bienestar de la comunidad. La DPA se opone a los enfoques punitivos que desestabilizan a las personas, bloquean el acceso a la atención médica y agotan los recursos de las comunidades. Creemos que la regulación de las drogas debe basarse en la evidencia, la salud, la equidad y los derechos humanos. En colaboración con otros movimientos, cambiamos las leyes, promovemos la justicia y salvamos vidas.
El Centro de Acción Legal (LAC) Es una organización legal y de políticas que trabaja para combatir la discriminación, promover la equidad en salud y restaurar las oportunidades para las personas y comunidades afectadas por el sistema judicial penal, el consumo de sustancias y las afecciones de salud mental, y/o el VIH/SIDA. LAC busca erradicar y revertir las políticas punitivas sobre drogas que han impulsado el encarcelamiento masivo y no han contribuido a mitigar la actual crisis de sobredosis; eliminar el estigma generalizado que rodea al trastorno por consumo de sustancias y el tratamiento basado en la evidencia; y crear un acceso equitativo a una atención comunitaria asequible y de calidad. LAC visualiza una sociedad que defiende los derechos civiles de todas las personas, independientemente de su condición médica y/o antecedentes de arresto/condena, y busca desmantelar el racismo estructural en nuestros sistemas de salud y justicia, que ha causado daños desproporcionados a las personas negras y morenas en todo el país.